Daiwa Securities Group Inc. Assembly Biosciences, Inc. Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$2.13 - $3.46 $153 - $249	-72 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$4.87 - $17.29 $555 - $1,971	-114 Reduced 61.29%	72 $0
Q3 2020 Nov 02, 2020	BUY	$15.08 - $27.04 $588 - $1,054	39 Added 26.53%	186 $3,000
Q4 2019 Jan 31, 2020	BUY	$8.36 - $23.81 $1,228 - $3,500	147 New	147 $3,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.